Estrogen Receptor Variants, HDL, and Atherosclerosis
NCT00081705 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-07-29
Summary
To measure the association between estrogen receptor variants and the extent of atherosclerosis in the thoracic and abdominal aorta and the right coronary artery in subjects in the PDAY study.
Conditions
- Cardiovascular Diseases
- Atherosclerosis
- Coronary Arteriosclerosis
- Heart Diseases
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
David Herrington · Wake Forest University Health Sciences
Eligibility
- Min Age
- 15 Years
- Max Age
- 34 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-03-31
- Primary Completion
- 2007-02-28
- Completion
- 2007-02-28
More Related Trials
-
The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation
NCT00579098 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Statins on Lower Extremity Arterial Function Assessed by Magnetic Resonance Imaging
NCT00770679 ·Status: TERMINATED ·Phase: NA
-
Association of Genetic Polymorphisms With Lipid Lowering Effects of Statin Therapy
NCT00509574 ·Status: UNKNOWN
-
Evaluation of Atorvastatin on Atherosclerosis Composition
NCT00576576 ·Status: COMPLETED ·Phase: NA
-
Pharmaco-metabolomic Effects of Statins: METASTATINE
NCT03837925 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease
NCT00770575 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacogenomic Modulators of Impaired Exercise Adaptation in Statin Users
NCT04636138 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention
NCT00588471 ·Status: TERMINATED ·Phase: NA
-
The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue
NCT00587717 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis
NCT00570752 ·Status: COMPLETED ·Phase: PHASE2
-
Role of A2A Receptor in Hypercholesterolemic Patients
NCT05017649 ·Status: RECRUITING ·Phase: NA
-
Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells
NCT00166036 ·Status: COMPLETED ·Phase: PHASE2
-
Influence of Lipid Lowering on Impaired Coronary Flow
NCT05368545 ·Status: COMPLETED ·Phase: NA
-
Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
NCT01761656 ·Status: UNKNOWN ·Phase: PHASE2
-
Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients
NCT02561845 ·Status: WITHDRAWN
-
Early Atherosclerosis Change in Two Clinical Trials
NCT00005696 ·Status: COMPLETED
-
Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy
NCT01634906 ·Status: COMPLETED ·Phase: NA
-
Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome
NCT01223586 ·Status: COMPLETED
-
The Effect of Statin Treatment on Arterial Wall Inflammation as Assessed With 68Ga-DOTATATE PET-CT
NCT05730634 ·Status: COMPLETED ·Phase: NA
-
The Effect on EPCs by Statin Loading in "All Comers" With an ACS
NCT02957162 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Statin Therapy on Adaptations to Aerobic Exercise
NCT03360916 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Atorvastatin 80 mg on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in PCI-STEMI Patients
NCT06871358 ·Status: COMPLETED ·Phase: NA
-
Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging
NCT00368589 ·Status: COMPLETED
-
Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis
NCT00485121 ·Status: COMPLETED ·Phase: NA
-
The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia
NCT00329069 ·Status: COMPLETED ·Phase: NA